148 related articles for article (PubMed ID: 33331618)
1. Ongoing Research Protocols for the Pharmacological Treatment of Neuropsychiatric Symptoms in Dementia.
Canevelli M; Remoli G; Toccaceli Blasi M; Tariciotti L; Sarli G; Valletta M; D'Antonio F; Vanacore N; Cesari M; Bruno G
J Frailty Aging; 2021; 10(1):22-30. PubMed ID: 33331618
[TBL] [Abstract][Full Text] [Related]
2. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.
Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T
Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555
[TBL] [Abstract][Full Text] [Related]
3. Update on SSRI Treatment for Neuropsychiatric Symptoms of Dementia.
Wilkins JM; Forester BP
Curr Psychiatry Rep; 2016 Feb; 18(2):14. PubMed ID: 26781552
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of nonpharmacological interventions for the management of neuropsychiatric symptoms in patients with dementia: a systematic review.
Ayalon L; Gum AM; Feliciano L; Areán PA
Arch Intern Med; 2006 Nov; 166(20):2182-8. PubMed ID: 17101935
[TBL] [Abstract][Full Text] [Related]
5. Behavior and Evolution of Young ONset Dementia part 2 (BEYOND-II) study: an intervention study aimed at improvement in the management of neuropsychiatric symptoms in institutionalized people with young onset dementia.
van Duinen-van den IJssel JCL; Appelhof B; Zwijsen SA; Smalbrugge M; Verhey FRJ; de Vugt ME; Zuidema SU; Koopmans RTCM; Bakker C
Int Psychogeriatr; 2018 Mar; 30(3):437-446. PubMed ID: 28595662
[TBL] [Abstract][Full Text] [Related]
6. Report on an open-label prospective study of divalproex sodium for the behavioral and psychological symptoms of dementia as monotherapy and in combination with second-generation antipsychotic medication.
Forester B; Vanelli M; Hyde J; Perez R; Ahokpossi C; Sribney W; Adkison L
Am J Geriatr Pharmacother; 2007 Sep; 5(3):209-17. PubMed ID: 17996660
[TBL] [Abstract][Full Text] [Related]
7. Atypical antipsychotics for the treatment of dementia-related behaviors: an update.
Daiello LA
Med Health R I; 2007 Jun; 90(6):191-4. PubMed ID: 17633594
[TBL] [Abstract][Full Text] [Related]
8. Neuropsychiatric symptoms in patients with dementia in primary care: a study protocol.
Borsje P; Wetzels RB; Lucassen PL; Pot AM; Koopmans RT
BMC Geriatr; 2014 Mar; 14():32. PubMed ID: 24628730
[TBL] [Abstract][Full Text] [Related]
9. Effects of a Multidisciplinary Intervention on the Presence of Neuropsychiatric Symptoms and Psychotropic Drug Use in Nursing Home Residents WithYoung-Onset Dementia: Behavior and Evolution of Young-Onset Dementia Part 2 (BEYOND-II) Study.
Appelhof B; Bakker C; de Vugt ME; van Duinen-van den IJssel JCL; Zwijsen SA; Smalbrugge M; Teerenstra S; Verhey FRJ; Zuidema SU; Koopmans RTCM
Am J Geriatr Psychiatry; 2019 Jun; 27(6):581-589. PubMed ID: 30799167
[TBL] [Abstract][Full Text] [Related]
10. Progresses in treating agitation: a major clinical challenge in Alzheimer's disease.
Panza F; Solfrizzi V; Seripa D; Imbimbo BP; Santamato A; Lozupone M; Prete C; Greco A; Pilotto A; Logroscino G
Expert Opin Pharmacother; 2015; 16(17):2581-8. PubMed ID: 26389682
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and feasibility of nonpharmacological interventions for neuropsychiatric symptoms of dementia in long term care: a systematic review.
Seitz DP; Brisbin S; Herrmann N; Rapoport MJ; Wilson K; Gill SS; Rines J; Le Clair K; Conn D
J Am Med Dir Assoc; 2012 Jul; 13(6):503-506.e2. PubMed ID: 22342481
[TBL] [Abstract][Full Text] [Related]
12. Risperidone for the treatment of behavioral and psychological symptoms of dementia.
Tune LE
J Clin Psychiatry; 2001; 62 Suppl 21():29-32. PubMed ID: 11584986
[TBL] [Abstract][Full Text] [Related]
13. The course of neuropsychiatric symptoms in patients with dementia in primary care.
Borsje P; Lucassen PLBJ; Bor H; Wetzels RB; Pot AM; Koopmans RTCM
Fam Pract; 2019 Jul; 36(4):437-444. PubMed ID: 30517631
[TBL] [Abstract][Full Text] [Related]
14. Galantamine versus risperidone treatment of neuropsychiatric symptoms in patients with probable dementia: an open randomized trial.
Freund-Levi Y; Jedenius E; Tysen-Bäckström AC; Lärksäter M; Wahlund LO; Eriksdotter M
Am J Geriatr Psychiatry; 2014 Apr; 22(4):341-8. PubMed ID: 24035407
[TBL] [Abstract][Full Text] [Related]
15. Tetrahydrocannabinol for neuropsychiatric symptoms in dementia: A randomized controlled trial.
van den Elsen GA; Ahmed AI; Verkes RJ; Kramers C; Feuth T; Rosenberg PB; van der Marck MA; Olde Rikkert MG
Neurology; 2015 Jun; 84(23):2338-46. PubMed ID: 25972490
[TBL] [Abstract][Full Text] [Related]
16. TIME - Targeted interdisciplinary model for evaluation and treatment of neuropsychiatric symptoms: protocol for an effectiveness-implementation cluster randomized hybrid trial.
Lichtwarck B; Selbaek G; Kirkevold Ø; Rokstad AM; Benth JŠ; Myhre J; Nybakken S; Bergh S
BMC Psychiatry; 2016 Jul; 16():233. PubMed ID: 27406242
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacological treatment of behavioral symptoms in dementia patients].
Gabryelewicz T
Przegl Lek; 2014; 71(4):215-20. PubMed ID: 25141581
[TBL] [Abstract][Full Text] [Related]
18. Aggressive behavior in patients with dementia: correlates and management.
Cipriani G; Vedovello M; Nuti A; Di Fiorino M
Geriatr Gerontol Int; 2011 Oct; 11(4):408-13. PubMed ID: 21843201
[TBL] [Abstract][Full Text] [Related]
19. Course of neuropsychiatric symptoms in residents with dementia in long-term care institutions: a systematic review.
Wetzels R; Zuidema S; Jansen I; Verhey F; Koopmans R
Int Psychogeriatr; 2010 Nov; 22(7):1040-53. PubMed ID: 20678299
[TBL] [Abstract][Full Text] [Related]
20. Neuropsychiatric symptoms and psychotropic drug use in patients with dementia in general practices.
Borsje P; Lucassen PLBJ; Wetzels RB; Pot AM; Koopmans RTCM
Fam Pract; 2018 Jan; 35(1):22-28. PubMed ID: 28985387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
